"Some die with meningioma, some die from meningioma."

01What Is a Meningioma?

Meningiomas are tumors that develop from the meninges — specifically the arachnoid layer, one of the three membranous layers (dura, arachnoid, and pia mater) that surround and protect the brain and spinal cord. They are the most common type of primary brain tumor. The majority — roughly 80–85% — are benign (WHO Grade I) and grow slowly, sometimes over many years. A smaller portion are atypical (Grade II) or, rarely, malignant (Grade III), which grow faster and are more likely to recur after treatment.

Many meningiomas are found incidentally, during imaging performed for an unrelated reason — a significant number of patients have no symptoms at all at the time of diagnosis.

02Grades and Subtypes

Grade IBenign, slow-growing. The majority of cases.
Grade IIAtypical — grows faster, higher recurrence risk.
Grade IIIMalignant (anaplastic) — rare, requires aggressive treatment.

03Symptoms

Symptoms depend heavily on the tumor's location and size. Common presentations include:

  • Persistent or worsening headaches
  • Seizures
  • Vision changes or double vision
  • Weakness or numbness in an arm or leg
  • Changes in personality, memory, or speech (depending on location)
  • No symptoms at all — an incidental finding on imaging

04Diagnosis

Contrast-enhanced MRI is the standard diagnostic tool and typically shows a characteristic pattern (including the classic "dural tail" sign). CT imaging may be used to assess bone involvement. A definitive grade is confirmed through pathological analysis of tissue obtained during surgery.

05Treatment Options — Overview

Not every meningioma requires immediate surgery. The right approach depends on the tumor's size, whether growth has actually been documented over time, its location, and the patient's age and overall condition.

Observation is the right first step for a small, asymptomatic tumor found incidentally, where no growth has yet been documented. These are followed with periodic MRI scans rather than treated outright — many stay stable for years.

Surgery becomes the right approach once growth is confirmed on follow-up imaging, particularly in a younger patient, and it remains the only realistic option once a tumor is large enough to compress the brain or nearby structures, regardless of age.

Stereotactic Radiosurgery (SRS) is usually preferred over an operation for a small tumor with documented growth, or a medium-sized tumor, in an older patient — and for tumors in high-risk locations such as the cavernous sinus, where complete surgical removal is unlikely without unacceptable risk.

Treatment Roadmap

How We Approach It

Explore how the decision is made for meningioma, and what a typical surgical journey looks like.

Diagnosis Confirmed

Contrast-enhanced MRI identifies the tumor and its relationship to surrounding structures.

Multidisciplinary Evaluation

Size, growth rate, location, and the patient's age and symptoms are assessed together — with input from radiation oncology / the SRS team whenever radiosurgery is a candidate option.

The Decision Branches

From here, the recommended path depends on the clinical picture. Tap a profile to see the reasoning:

Found incidentally, with no confirmed growth over time. Periodic MRI monitoring is the right first step — many stay stable for years.
Choosing radiosurgery instead means committing to decades of follow-up imaging — for a younger patient, definitively removing the tumor now is often the more sound long-term decision.
Once a meningioma is large enough to compress the brain or nearby structures, surgery is the only realistic option — radiosurgery cannot safely treat a tumor this size.
Delay is not advisable here. As symptoms progress, patients become progressively poorer candidates for surgery — early intervention offers the greatest chance of significant neurological recovery.
Age changes the calculus, not the decision to treat. Radiosurgery controls the tumor while avoiding surgical risk — a better trade-off than an operation at this age and size.
When complete surgical removal is unlikely without unacceptable risk to critical structures, radiosurgery is the safer and generally more effective choice — even if surgery is technically possible.
Follow-Up

Whichever path is taken, long-term imaging follow-up confirms the tumor remains controlled.

Pre-Op Preparation

Imaging studies (MRI/CT), lab work, anesthesia clearance, and admission planning.

Day 0 Surgery Day

The operation is performed, followed by post-op imaging to confirm the result.

Day 1 First Postoperative Day

Close monitoring, typically in intensive care, with neurological examination and wound checks.

Day 4 Discharge Day

Neurological exam confirms stability; patient is discharged home with wound-care instructions.

Day 10 Follow-Up

Wound follow-up and suture removal, with a neurological exam confirming recovery before travel home.

Shown for a typical, uncomplicated case. Individual recovery may vary.